Katarzyna Kapłon

Dr. Katarzyna Kapłon

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JFJakub Fiegler-Rudol
Jakub Fiegler-Rudol
KKKatarzyna Kapłon
Katarzyna Kapłon
KKKornela Kotucha
Kornela Kotucha
MMMagdalena Moś
Magdalena Moś
DSDariusz Skaba
Dariusz Skaba
RWRafał Wiench
Rafał Wiench
Photodynamic therapy (PDT) is a light-activated treatment that generates reactive oxygen species (ROS) to induce microbial cell death. As resistance to traditional antibiotics intensifies globally, PDT has emerged as a promising alternative or adjunctive antimicrobial strategy. Among various photosensitizers, Hypocrellin, a perylenequinone compound, has shown high ROS yield and broad-spectrum activity against bacteria and fungi. This systematic review evaluated the efficacy, safety, and therapeutic potential of Hypocrellin-mediated antimicrobial photodynamic therapy. Following PRISMA 2020 guidelines, a comprehensive literature search was conducted in PubMed, Embase, Scopus, and the Cochrane Library for studies published between 2015 and 2025. Eligible studies included in vitro and preclinical in vivo research using Hypocrellin as a photosensitizer. Quality and risk of bias were assessed using a structured nine-item checklist. Ten eligible studies, all conducted in China, were included. Hypocrellin-mediated aPDT significantly reduced microbial loads in both planktonic and biofilm states of resistant pathogens such as Candida albicans, Candida auris, Cutibacterium acnes, and Staphylococcus aureus. The treatment acted via ROS-mediated apoptosis, membrane disruption, and mitochondrial dysfunction, with minimal cytotoxicity to mammalian cells. Studies also reported enhanced efficacy when Hypocrellin was incorporated into nanocarriers, polymeric scaffolds, or combined with chemodynamic or photothermal therapies. However, substantial heterogeneity was observed in Hypocrellin concentrations, irradiation parameters, and outcome measures. Hypocrellin-based PDT exhibits potent antimicrobial activity and favorable safety in preclinical settings, supporting its potential as an alternative to conventional antibiotics. However, standardized treatment protocols and robust clinical trials are urgently needed to validate long-term safety and translational feasibility. These findings underscore the broader promise of PDT in addressing drug-resistant infections through a mechanism unlikely to induce resistance.

Verified
Journal Article
Open access
PDF file
JFJakub Fiegler-Rudol
Jakub Fiegler-Rudol
BLBarbara Lipka
Barbara Lipka
KKKatarzyna Kapłon
Katarzyna Kapłon
MMMagdalena Moś
Magdalena Moś
DSDariusz Skaba
Dariusz Skaba
RWRafał Wiench
Rafał Wiench
Candida albicans is a significant pathogen in various fungal infections, including oral candidiasis and denture stomatitis. As antifungal resistance rises globally, there is an urgent need for alternative treatment strategies. Antimicrobial photodynamic therapy (aPDT), utilizing a photosensitizer and light to produce reactive oxygen species (ROS), has emerged as a promising approach. Rose Bengal (RB), a xanthene dye, exhibits a high singlet oxygen quantum yield, making it a candidate for aPDT. However, its efficacy in C. albicans treatment has been inconsistent, particularly against biofilm-associated infections, which are more resistant to conventional therapies. This systematic review evaluates the efficacy of Rose Bengal-mediated aPDT in combating C. albicans infections by synthesizing data from studies conducted over the past decade. We focus on the effectiveness of RB across different experimental conditions, including planktonic and biofilm forms of C. albicans. The review also explores the synergy between RB and other agents, such as potassium iodide, and compares the outcomes of RB-mediated aPDT to other photosensitizers and conventional antifungal treatments. Despite its potential, RB-aPDT shows variable effectiveness due to differences in experimental protocols, such as the photosensitizer concentration, incubation times, and light parameters. The review identifies the key limitations, such as RB’s poor biofilm penetration and high dark toxicity at elevated concentrations, which hinder its clinical applicability. The combination of RB with potassium iodide enhances its antifungal efficacy, suggesting that further optimization could improve its clinical potential. Overall, while Rose Bengal-mediated aPDT holds promise as a novel antifungal treatment, further research is needed to standardize protocols, enhance delivery systems, and validate its efficacy in vivo and clinical settings.

1 July 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JKJoanna Kaźmierczak
Joanna Kaźmierczak
AJAnna Jurczak
Anna Jurczak
PKPaweł Kiełbasa
Paweł Kiełbasa
WKWeronika Komala
Weronika Komala
CRCyryl Rabcewicz
Cyryl Rabcewicz
JGJacek Góra
Jacek Góra
Introduction and purpose Microelements are essential nutrients required in small amounts but have profound physiological and biochemical roles in human reproduction. The main purpose of this review is to present the current state of knowledge regarding the effects of zinc, selenium, iodine, copper, iron, manganese, and magnesium on male and female fertility. The analysis highlights how deficiencies, excesses, and synergistic interactions among these elements affect gametogenesis, hormonal balance, oxidative stress, epigenetic modifications, and pregnancy outcomes. Through a synthesis of clinical, biochemical, and epidemiological findings, this paper emphasizes the need for micronutrient optimization as an adjunct strategy in managing infertility. Material and methods This review follows a comprehensive narrative synthesis approach to evaluate the role of microelements in human fertility, with a focus on zinc, selenium, iodine, copper, iron, manganese, and magnesium. A review was based on the analysis of 44 peer-reviewed articles, clinical, biochemical, and epidemiological studies published between 2015 and 2025. The primary objective was to critically assess the relationship between micronutrient status and fertility outcomes in both male and female populations. Studies were selected based on predefined eligibility criteria, which included research on micronutrient supplementation or deficiency, reproductive outcomes, and evidence from randomized controlled trials (RCTs), cohort studies, and meta-analyses.Conclusions Recent research highlights the synergistic effects of these elements, showing that deficiencies or imbalances can exacerbate fertility issues. Optimizing micronutrient levels is becoming an important strategy in fertility management, with potential benefits for both natural conception and assisted reproductive technologies (ART).

30 December 2025 in European Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
KKKornela Kotucha
Kornela Kotucha
KKKatarzyna Kapłon
Katarzyna Kapłon
MMMagdalena Moś
Magdalena Moś
JFJakub Fiegler-Rudol
Jakub Fiegler-Rudol
APAlina Pietryszyn-Bilińska
Alina Pietryszyn-Bilińska
Aleksandra Kawczyk-KrupkaAleksandra Kawczyk-Krupka
Aleksandra Kawczyk-Krupka
Introduction and aim. The most common metabolic disorders include type 2 diabetes (T2DM) and obesity. Their prevalence has increased in recent years. Due to their widespread prevalence and the fact that they increase the risk of cardiovascular disease, morbidity, and mortality, they pose a significant economic burden to the healthcare system. In this review, we will focus primarily on the role of gut hormone signaling produced by enteroendocrine cells (EECs), which are part of the gut-brain axis. Furthermore we will summarize applications of these mechanisms in novel therapies for T2DM and obesity. Material and method. Literature data analysis was performed using the following databases: PubMed (MEDLINE), Scopus, Web of Science and Google Scholar. The review included articles in Polish and English published between 2000 and 2024. Analysis of the literature. EECs are specialized transepithelial cells present throughout the intestine. The best-studied EEC subtype is the L cell, which secretes glucagon-like peptide-1 (GLP-1). GLP-1 regulates insulin secretion and contributes to satiety by increasing insulin secretion and inhibiting glucagon secretion. Significant progress in the use of intestinal hormones in the treatment of T2DM and obesity has led to the development of effective therapies for both of these conditions, such as GLP-1 analogs. Conclusion. The growing understanding of biochemical processes, hormonal signaling, and the development of new technologies contribute to the continuation of research on new, more effective therapies that use mechanisms of action of the gut-brain axis. Despite these achievements, the need for new and more effective treatments is constantly growing, and requires innovative strategies and their potential combination with existing therapies.